Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sanborn, RE; Pishvaian, MJ; Callahan, MK; Weise, AM; Sikic, BI; Rahma, OE; Cho, DC; Rizvi, NA; Bitting, RL; Starodub, A; Jimeno, A; Yellin, MJ; Rawls, T; Vitale, L; Halim, A; Zhang, H; Keler, T

Published Date

  • May 20, 2018

Published In

Volume / Issue

  • 36 / 15_suppl

Start / End Page

  • 3001 - 3001

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2018.36.15_suppl.3001